Be advised that review time averages 4-6 months.
The Journal of Clinical Anesthesia (JCA) publishes definitive,
peerreviewed
articles devoted to the clinical practice of anesthesia.
The JCA should be a participant in continuing education
of
clinicians, forecast important issues and trends in anesthesia and
foster responsible debate on controversial issues. As an international
journal, it encourages cross-communication between different cultures,
informing our readers about medical and sometimes non-medical
journalism, and provides enjoyable reading. Advertising between the
pages of editorial content is not permitted.
The editors of JCA
welcome the submission of manuscripts devoted
to the clinical practice of anesthesia. Statements contained therein
are the responsibility
of the author(s). Each manuscript is considered
for publication with the following understandings: 1) All persons
designated as authors
should qualify for authorship. The order of
authorship should be a joint decision of the co-authors. Each author
should have participated
sufficiently in the work to take public responsibility
for the content. Authorship credit should be based only on a substantial
contributions
to (a) conception and design, or analysis and
interpretation of data; and to (b) drafting the article or resizing it critically
for important
intellectual content; and on (c) final approval of
the version to be published. Conditions (a), (b), and (c) must all be
met. Participation
solely in the acquisition of funding or the collection
of data does not justify authorship. General supervision of the
research group
is not sufficient for authorship. Any part of an article
critical to its main conclusions must be the responsibility of at least
one
author. 2) Ghostwriting: It is unacceptable for a person who lends
the use of his or her name to a manuscript (whether or not a fee has
been paid for the use of that name), when the manuscript has been
written by another person/persons who do not identify themselves,
their
affiliation, or potential or real conflicts of interest. Therefore,
ghostwritten articles will be immediately rejected. 3) None of the
material
in the manuscript has been published previously nor is any of the
material currently under consideration for publication elsewhere
(including
tables, illustrations, etc.) in any other journal. The author should
make a full statement to the editor about all submissions
and previous
reports that might be regarded as prior or duplicate publication of
the same or very similar work (see Acceptable Secondary
Publication section
below). Copies of such material should be included in the submitted
paper for the editors' review.
All manuscripts
accepted for publication in JCA become the sole
property of the publisher. The publisher reserves copyright and renewal
in all
published material, which may not be reproduced in any form
without the written permission of the publisher. If a manuscript is
accepted
for publication, the author(s) will be asked to assign copyright
to the publisher.
Acceptable Secondary Publication
Secondary
publication in the same or another language, especially in
other countries, is justifiable, and can be beneficial, provided all of
the
following conditions are met:
- The authors have received approval from the editors of both
journals; the editor concerned
with secondary publication must have
a photocopy, reprint, or manuscript of the primary version.
- The priority of the primary
publication is respected by a publication
interval of at least one week (unless specifically negotiated
otherwise by both editors).
-
The paper for secondary publication is intended for a different
group of readers; an abbreviated version could be sufficient.
-
The secondary version reflects faithfully the data and interpretations
of the primary version.
- A footnote on the title page
of the secondary version informs
readers, peers, and documenting agencies that the paper has been
published in whole or in part, and
states the primary reference. A
suitable foot note might read: "This article is based on a study first
reported in [title of journal,
with full reference]."
Permission for such secondary publication should be free of charge.
MANUSCRIPTS
Authors
are requested to register at this site ( http://ees.elsevier.com/jca )
and to submit their manuscript and any artwork as
usable electronic
files (not as PDFs). In an accompanying letter, authors should state
that the manuscript, or parts of it, have not
been and will not be
submitted elsewhere for publication.
Submission items include a cover letter (saved as a separate file for
upload),
suggested reviewers, the manuscript file (including a title
page, abstract, main text, references, and table/figure legends), and
any
tables and figures (saved as separate files). If you have submitted
via the Web-based site and are asked to revise your manuscripts,
you
will be asked to include a unique file (separate from the covering
letter) with responses to reviewers' comments. The preferred order
of
files is as follows: cover letter, suggested reviewers, response to reviews
(revised manuscripts only), manuscript file, table(s),
figure(s). Files
should be labeled with appropriate and descriptive file names
(e.g., SmithText.doc, Fig1.eps, Table3.doc). Upload text,
tables, and
graphics as separate files. If your figures are large or you have many
of them, you can compress them all in a Zip file and
upload it as one
item, properly named (e.g., Figures 1-7). The system will unpack the
separate files and prompt you to name each one.
Do not import
figures or tables into the text document and, again, do not upload
your text as a PDF. Complete instructions for
electronic artwork
submission can be found on the Author Gateway (at www.authors.elsevier.com),
which is also accessible through the journal's submissions
home page.
Authors who are unable to provide an electronic version or have
other circumstances that prevent online submission must contact
the Editorial Office prior to submission to discuss alternate options.
The Publisher and Editors regret that they are not able to consider
submissions that do not follow these procedures.
Manuscript
Submission Preparation:
When submitting online via our Web-based system ( http://ees.elsevier.com/jca ), authors must
upload the following items as separate files: a
cover letter, an abstract, the manuscript, and any tables, figures, and
figure legends.
Revised or resubmitted manuscripts should also include
a transmittal letter, explaining how the author has dealt with each of
the reviewer's
and Editor's comments and these comments should be
uploaded as a 'Revision Comments' file on the system.
File formats
For online submission,
please use MS Word for the text files. Graphics
should be saved as TIFF, EPS, or MS Office.
- Provide a cover letter indicating
the name, address, tel., fax, and
email addresses of the individual to whom correspondence and
questions should be directed. Include
a statement in the cover
letter that the contents have not been published elsewhere and
the paper is not being submitted elsewhere. Also
indicate that the
manuscript has been read and approved by all co-authors. Finally,
indicate to which category of publication the author
is submitting
the article: Original Contribution, Editorial, Case Report, Grand
Rounds, Pharmacologic Review, Special Article (history,
art,
politics, etc.), Letter to the Editor.
- Arrange the manuscript in the following order: title page,
abstract (structured
abstract if the work is an Original contribution
only), text, acknowledgments, references, tables, legends for
illustrations, and illustrations.
- Text: Arrange the body of the manuscript in the following order:
(Structured) Abstract, Introduction, Materials and Methods,
Results,
Discussion, with each component beginning on a new page.
- Number the pages in sequence, with the title page as page
1, the
(structured) abstract as page 2, etc., with the page number in the
upper right-hand corner.
Formatting of Text
- Type all manuscripts with double line spacing and aligned left,
including the abstract, references, and figure legends.
-
Use the Times New Roman 12-point font/size.
- Manuscripts should have continuous line numbers, page numbers
and wide margins
throughout (including the abstract, references,
figure legends and tables).
- Indent each new paragraph.
- Use two returns
to end headings and paragraphs.
- Do not use lower-case 'l' (el) for '1' (one) or 'O'(oh) for '0' (zero);
they have different
typesetting values.
TITLE PAGE
- Give the first name, middle initial, and last name of all authors.
List
each author's highest academic degree and provide the study
affiliation (i.e., all departments and institutions from which the manuscript
originated). All authors must fully meet the criteria for
authorship as defined in the uniform requirements for manuscripts
submitted
to medical journals or N Engl J Med 1997; 336:309-15.
- Provide the name, address, and email address of the corresponding
author to whom reprint requests should be sent.
- Show the address of each author at the time of the study and include
the present
address if it differs.
- Provide a running title of up to 50 characters.
- Acknowledge grants, sponsors, and funding
sources that provided
direct financial support to the research work contained in the manuscript.
Use terms from the U.S.
Library of Medicine's Medical Subject
Headings (MeSH) Annotated Alphabetical List for indexing purposes in
Index Medicus.
ABSTRACTS
All Original Contributions require a structured abstract of up to 300
words, which clearly states the following (use
these subheadings): 1)
Study Objective, 2) Design—i.e, the type of study conducted, 3)
Setting—e.g., delivery room, postoperative
recovery area, operating
room; 4) Patients?number studied, their ASA physical status, the
nature of their procedure and illness; 5) Interventions—what
was done
to the patients on behalf of the study, 6) Measurements - e.g., blood
pressure, heart rate, resp. rate values collected; 7)
Main Results - the
study's principal finding of interest, 8) Conclusions?based on the
kinds of patients studied and the interventions
used, what conclusions
may be drawn from the main findings of interest. The structured
abstract should provide key information and be
informative on its
own, although it should not include discussion of pros and cons,
limitations or justifications of the study.
Except
for letters to the editorial and editorials, all other types of
publications (case reports, review articles, special articles, and Grand
Rounds), require a brief, standard abstract of a few sentences. Do not
cite references or use abbreviations in the structured (or other)
abstract.
List up to six keywords applicable to the contents of the manuscript.
The keywords will be used for indexing purposes.
TEXT
Start the text on a new page. Arrange the text into four parts:
- Introduction: The rationale for the
study. Do not include an extensive
literature review.
- Materials and Methods: A clear and precise description of the
experiment and the subjects from whom the data were derived. If
subjects were randomized, describe the methods of randomization
used.
Identify all drugs and chemicals used, dosages, and routes of
administration. Define all statistical methods used and, if appropriate,
statistical references. Identify the name and address of the statistician
who reviewed the data, if appropriate.
- Results:
A factual account of the study's findings. Present these as
logically appropriate in text, tables, or illustrations; do not repeat in
the text what is demonstrated in a table or illustration.
- Discussion: A summary emphasizing new and important aspects
of
the study's conclusions. Ensure that all conclusions are justified by the
results of the study. Identify the implications of the findings
and their
limitations, including implications for future research. Look at the
pros and cons of the methods and results. Compare the
implications
and limitations of these findings with those reported in other essential
studies. State new hypotheses when warranted, but
clearly label
them as such. Recommendations, where appropriate, may be included.
ACKNOWLEDGMENTS
Funding sources
and corporate or institutional associations should be
given on the title page. Acknowledgments to individuals who assisted
with the study
or with manuscript preparation, including statistical
review, should appear just before the references.
REFERENCES
References
must be publicly available and verified by the authors and
against the original documents. If the reference is not publicly available,
refer to the material in a footnote within the text. Any references
to published abstracts must be less than three years old. Number
references sequentially in the order of their citation in the manuscript.
The reference list appears immediately after the text and
Acknowledgments.
For each citation, include all names unless the
authors number seven or more; in that case, list three names followed
by "et al." Do
not use periods after authors' initials. Provide inclusive
page numbers for journal articles and specific page citations for books.
Identify
abstracts and letters. Style references according to "International
Committee of Medical Journal Editors: Uniform requirements for
manuscripts
submitted to biomedical journals." N Engl J Med 1997;
336:309-15.
- Journal citation: Eichhorn JH, Cooper JB, Cullen
DJ, et al. Anesthesia
practice standards at Harvard: a review. J Clin Anesth 1988;1:55-65.
- Book citation: Thompson
T, Kanton B. Hormonal and metabolic
considerations in the acutely ill patient, 2nd ed. New York: Timely Publications,
1987:115-25,209-301.
- Chapter in a book: Baldwin T: Effective infusion therapy. In: Pronter K,
Baldwin T, Senthoff V (eds): Insulin Infusion
System Delivery. Baltimore:
Immediate Press Publishers, 1986:88-152.
TABLES
Each table should be uploaded
as a separate file. Provide a number
(1,2,3, etc.) and title for each table. Abbreviations may be used to simplify
a table; define all
abbreviations in a single footnote. Number
tables consecutively in the order of their first citation in the text.
Identify statistical
measures of variation such as standard deviation
and standard error of the mean.
LEGENDS FOR ILLUSTRATIONS ("Figures")
Provide
a full legend for each illustration. In the legend, identify and
define all abbreviations, symbols, arrows, and illustration parts.
ILLUSTRATIONS ("Figures")
Number illustrations sequentially according to their first appearance
in the text. If photographs
of persons are submitted, either the subjects
must not be identifiable or their pictures must be accompanied
by written permission to
use the photograph. Under special circumstances,
color photographs can be published at a rate agreed upon
between the authors and the
publishers.
Figures
- Upload figures as separate files, or Zip all figures together and
upload them at one step.
(To download a trial version of WinZip, go
to www.winzip.com.)
- A
figure and its legend should be sufficiently informative that the
results can be understood without reference to the text. Figure
legends
should not appear on the same page as figures, but in
the manuscript text file (after references).
- The publisher will charge
for printed color figures, but will publish color
figures electronically so upload both when submitting the manuscript.
- Figures
should be large enough to allow for reproduction but not
larger than letter size, and should be designed with the Journal
format in mind.
- The preferred point symbols are open circle, open square, open triangle,
filled circle, filled square, filled triangle. The
preferred shadings
are black, white and bold hatching. Avoid stippling, which does not
reproduce well. The preferred font for axis labels
and keys is Arial.
- Ticks should be drawn outside the figure axes; they should not be
extended to form lines across the whole
figure.
- Give keys and other explanations either in the legend or in the
figure caption.
- Number figures consecutively
in Arabic numerals.
- Abbreviate 'Figure' to 'Fig.' and 'Figures' to 'Figs' except when
starting a sentence.
PERMISSIONS
AND CREDITS
Illustrations, tables, or lengthy quotations taken from published sources
must be acknowledged with a full bibliographic
citation. The author's
and publisher's permission to reprint must be submitted as soon as
the manuscript receives final acceptance for
publication. One copy of
any article not accepted for publication will be kept by the JCA in its
files for six months.
DRUG
AND CHEMICAL NAMES
Refer to drugs by their approved generic names. If trade names are
used, the generic equivalent should be given
parenthetically at first
use. Identify compounds by their formal chemical name at first use;
thereafter the trivial name may be used.
CONSENT
In all manuscripts reporting the results of human studies, a statement
must appear in the Materials and Methods section
indicating that
approval was obtained from the institutional review board (IRB) and
that all human subjects signed written informed consent.
Cite in the
text the full (hospital) name of IRB. Do not identify human subjects
or patients.
CONFLICT OF INTEREST
JCA
expects all authors to disclose any commercial association that
might pose a conflict of interest for submitted article(s). Funding
sources
and corporate or institutional associations must be acknowledged
on the title page. In the cover letter accompanying the manuscript,
provide the names of associations, consultancies, individual
philanthropists, stock ownership, or other equity interest (e.g., patent
or licensing arrangements). If the manuscript is accepted for publication,
disclosure of this information will be discussed with the
author(s).
ADDITIONAL INFORMATION
The Journal's editor-in-chief is Robert R. Gaiser, MD. Direct
questions to the
editorial office at (508) 540-2197;
Fax (508) 540-2714; E-mail: jclinanes@comcast.net. |
